Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Español Near me My list Help
US Patient GuideUSA
Surprise me
Brand-name prescription medicine

ZYPREXA Intramuscular

Generic name: Olanzapine

FDA application holder: Cheplapharm

Strengths and generic versions

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

At a glance

1Strengths and forms
9Same medicine, other names
2004FDA approval
0Recalls (FDA reports)

Quick answers

What is ZYPREXA Intramuscular?
ZYPREXA Intramuscular is a brand name of Olanzapine, a prescription medicine. The FDA NDC Directory lists 1 ZYPREXA Intramuscular product in 1 strength and form.
Who makes ZYPREXA Intramuscular?
Cheplapharm holds the FDA application for ZYPREXA Intramuscular (NDA021253, approved March 29, 2004).
Is there a generic or store brand of ZYPREXA Intramuscular?
Yes. The FDA NDC Directory lists 9 other products with the same active ingredients, strength and form as a ZYPREXA Intramuscular product, 9 of them generic. Ask your pharmacist whether one is right for you.
Has ZYPREXA Intramuscular been recalled?
No recall linked to ZYPREXA Intramuscular products (by their NDC code or label) appears in the FDA enforcement reports we use.

What ZYPREXA Intramuscular is

Each ZYPREXA Intramuscular product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Olanzapine · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
olanzapine 10 mg/2 mL
injection, powder, for solution (intramuscular)		 ZYPREXA Intramuscular 9 products, 8 companies —

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Olanzapine →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of ZYPREXA Intramuscular products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA021253CheplapharmMarch 29, 20041

Companies that list ZYPREXA Intramuscular

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of ZYPREXA Intramuscular products.

Recalls

No recall linked to ZYPREXA Intramuscular products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers